Healio (8/3, Herpen) reports, “A once-weekly dose of transdermal donepezil proved a safe and effective equivalent to a daily dose of oral donepezil for Alzheimer’s-related dementia,” according to the findings of “an open-label, randomized, crossover, three-period trial with 60 volunteer participants aged 18 to 55 years” presented at the Alzheimer’s Association International Conference. (SOURCE: APA Headlines)